Literature DB >> 14505940

Formulation of a liquid ovine Fab-based antivenom for the treatment of envenomation by the Nigerian carpet viper (Echis ocellatus).

Ibrahim Al-Abdulla1, John M Garnvwa, Sophia Rawat, David S Smith, John Landon, Abdulsalami Nasidi.   

Abstract

Most antivenoms are required for use in tropical or sub-tropical countries where temperatures may be high and refrigerated storage unavailable or unreliable. Although freeze-dried products can be expected to have maximal storage stability, many antivenoms are manufactured in liquid form to lower their cost and ease their use. We developed a liquid formulation of an existing freeze-dried antivenom against the carpet viper (Echis ocellatus) for use in Nigeria. When Fab fragments, prepared from antisera raised in sheep, were exposed to pH between 3.0 and 8.0, time and temperature dependent precipitation of some populations of the Fab product occurred over the range 4.5-7.0. Formulation of the Fab fragments in acetate buffer (20 mM) at pH 4.0 provided a clear, colourless, particle-free and stable product which retained neutralising potency for at least one year at 4 degrees C and room temperature. An accelerated study indicated stability for at least 4 weeks at 37 degrees C which may be considered equivalent to four years at 4 degrees C. The presence of sugars (sorbitol at 20 g/l or mannitol at 50 g/l) or sodium chloride (153 mM) had no effect in stabilising Fab at high temperature (37 degrees C) and, in agreement with the prediction of these accelerated studies, no beneficial effect of mannitol was found in real-time studies after one year.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505940     DOI: 10.1016/s0041-0101(03)00170-3

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.

Authors:  Stuart D Dowall; Frédéric Jacquot; John Landon; Emma Rayner; Graham Hall; Caroline Carbonnelle; Hervé Raoul; Delphine Pannetier; Ian Cameron; Ruth Coxon; Ibrahim Al Abdulla; Roger Hewson; Miles W Carroll
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

2.  Antivenomic approach of different Crotalus durissus collilineatus venoms.

Authors:  Isadora Sousa de Oliveira; Manuela Berto Pucca; Suely Vilela Sampaio; Eliane Candiani Arantes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-11-26

Review 3.  The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.

Authors:  Harry F Williams; Harry J Layfield; Thomas Vallance; Ketan Patel; Andrew B Bicknell; Steven A Trim; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2019-06-20       Impact factor: 4.546

Review 4.  Assessment of the viral safety of antivenoms fractionated from equine plasma.

Authors:  Thierry Burnouf; Elwyn Griffiths; Ana Padilla; Salwa Seddik; Marco Antonio Stephano; José-María Gutiérrez
Journal:  Biologicals       Date:  2004-09       Impact factor: 1.856

5.  Roughness of Production Conditions: Does It Really Affect Stability of IgG-Based Antivenoms?

Authors:  Sanja Mateljak Lukačević; Tihana Kurtović; Juraj Borić; Beata Halassy
Journal:  Toxins (Basel)       Date:  2022-07-13       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.